Life Expectancy at Birth (2019): 83.4
Maternal Mortality Ratio (per 100,000 live births) (2017): 5
Neonatal Mortality Rate (per 1,000 live births) (2020): 3
Probability of Dying from any of Cardiovascular Disease, Cancer, Diabetes, Chronic Respiratory Diseases Between Age 30 and Exact Age 70 (%) (2019): 7.9%

Source: World health statistics 2022: monitoring health for the SDGs, sustainable development
goals. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.

Neonatal Mortality Rate (Deaths Per 1,000 Live Births) (2019): 3
Infant Mortality Rate (Deaths Per 1,000 Live Births) (2019): 4
Under-5 Mortality Rate (Deaths Per 1,000 Live Births) (2019): 4

Note: “Under-5 mortality rate – Probability of dying between birth and exactly 5 years of age, expressed per 1,000 live births.
“Infant mortality rate – Probability of dying between birth and exactly 1 year of age, expressed per 1,000 live births.
“Neonatal mortality rate – Probability of dying during the first 28 days of life, expressed per 1,000 live births.”

Source: United Nations Children’s Fund, The State of the World’s Children 2021: On My Mind – Promoting, protecting and caring for children’s mental health, UNICEF, New York, October 2021.

“Life expectancy at birth in 2013 was 80.7 years for men and 84.9 years for women (see Table 1.4), with average life expectancy of 82.8 being the second highest in the European Region (after Iceland). This was an increase in overall life expectancy of roughly 7 years compared to 1980, when life expectancy was 75.5 years. While female life expectancy has been above 80 years since 1990, male life expectancy has only surpassed 80 years since 2010.

“The disability-adjusted life expectancy (DALE) in 2012 was 70.5 years for women and 73.8 for men (see Table 1.5). Similarly, in 2012, healthy life year (HLY) expectancy, which is the number of years lived without any long-term activity limitations, was more than a year higher for men (68.6) than for women (67.6), meaning that women on average experience longer periods of sickness during their overall longer lifetime. Both for total life expectancy and for HLY Swiss averages are far above those of the EU28, indicating excellent population health.”

Source: De Pietro C, Camenzind P, Sturny I, Crivelli L, Edwards-Garavoglia S, Spranger A, Wittenbecher F, Quentin W. Switzerland: Health system review. Health Systems in Transition, 2015; 17(4):1–288.

“Population health indicators are very good in Switzerland. Patients are highly satisfied with the health system, perceive quality to be good or very good, and there are virtually no waiting times. Avoidable hospital admissions are relatively low and OECD quality indicators confirm that health care quality is high – although not exceptional.”

Source: De Pietro C, Camenzind P, Sturny I, Crivelli L, Edwards-Garavoglia S, Spranger A, Wittenbecher F, Quentin W. Switzerland: Health system review. Health Systems in Transition, 2015; 17(4):1–288.

Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems in the US and sixteen other nations.

Page last updated August 27, 2022 by Doug McVay, Editor.